EGFRvIII mCAR-Modified T-Cell Therapy Cures Mice with Established Intracerebral Glioma and Generates Host Immunity against Tumor-Antigen Loss

John H. Sampson, Bryan D. Choi, Luis Sánchez-Pérez, +12

Clinical Cancer Research

Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers

David I. Bernstein, Elizabeth A. Reap, Kevin S. Katen, +9

Vaccine

VaccinationVaccine DevelopmentImmunologyVaccine TrialVirology +4

Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma

Elizabeth A. Reap, Carter M. Suryadevara, Kristen A. Batich, +27

Cancer Research

A Supramolecular Vaccine Platform Based on α-Helical Peptide Nanofibers

Yaoying Wu, Pamela K. Norberg, Elizabeth A. Reap, +6

ACS Biomaterials Science & Engineering

Development and preclinical evaluation of an alphavirus replicon vaccine for influenza

Bolyn Hubby, Todd Talarico, Maureen F. Maughan, +14

Vaccine

VaccinationVaccine DevelopmentVaccine ResearchVaccine TargetImmunology +6

Cellular and Humoral Immune Responses to Alphavirus Replicon Vaccines Expressing Cytomegalovirus pp65, IE1, and gB Proteins

Elizabeth A. Reap, Sergey A. Dryga, J. Glenn Morris, +4

Clinical and Vaccine Immunology

Humoral Immune ResponsesGb ProteinsViral ImmunityViral PathogenesisImmunology +14

Severe Adverse Immunologic Reaction in a Patient with Glioblastoma Receiving Autologous Dendritic Cell Vaccines Combined with GM-CSF and Dose-Intensified Temozolomide

Duane A. Mitchell, Elias Sayour, Elizabeth A. Reap, +8

Cancer Immunology Research

BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomide

Luis Sánchez-Pérez, Bryan D. Choi, Elizabeth A. Reap, +9

Cancer Immunology Immunotherapy

Neuro-oncologyCancer ImmunosurveillanceBlys LevelsVaccine-induced Antibody TitersMedicine +11

CD27 stimulation unveils the efficacy of linked class I/II peptide vaccines in poorly immunogenic tumors by orchestrating a coordinated CD4/CD8 T cell response

Katherine A. Riccione, Li-Zhen He, Peter E. Fecci, +10

OncoImmunology

A conjoined universal helper epitope can unveil antitumor effects of a neoantigen vaccine targeting an MHC class I-restricted neoepitope

Adam M. Swartz, Kendra L. Congdon, Smita K. Nair, +8

npj Vaccines